chrisvoncsefalvay/vaers-outcomes huggingface dataset:
exceedingly dizzy and had a a very hazy mind; Was very weak-knees buckling; Stayed in bed and did only essential things and went back to bed; Brain fog; Dry tongue that was sticking to the top of my mouth; nose and cough were minor to nonexistent; sinus infection; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIZZINESS (exceedingly dizzy and had a a very hazy mind), ASTHENIA (Was very weak-knees buckling), MOBILITY DECREASED (Stayed in bed and did only essential things and went back to bed), FEELING ABNORMAL (Brain fog) and TONGUE DRY (Dry tongue that was sticking to the top of my mouth) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sinus infection (get these infections every winter), Bronchitis asthmatic, Pneumonia, Vertigo and Seasonal allergy.   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced DIZZINESS (exceedingly dizzy and had a a very hazy mind), ASTHENIA (Was very weak-knees buckling), MOBILITY DECREASED (Stayed in bed and did only essential things and went back to bed), FEELING ABNORMAL (Brain fog), TONGUE DRY (Dry tongue that was sticking to the top of my mouth), COUGH (nose and cough were minor to nonexistent) and SINUSITIS (sinus infection). At the time of the report, DIZZINESS (exceedingly dizzy and had a a very hazy mind), ASTHENIA (Was very weak-knees buckling), MOBILITY DECREASED (Stayed in bed and did only essential things and went back to bed), FEELING ABNORMAL (Brain fog), TONGUE DRY (Dry tongue that was sticking to the top of my mouth), COUGH (nose and cough were minor to nonexistent) and SINUSITIS (sinus infection) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Mar-2021, SARS-CoV-2 test: negative (Negative) negative.         The patient called his PC doctor. Doctor said the patient could have sinus infection as he get these every winters. He put him on antibiotics as corrective treatment. The antibiotics did seem to help, and patient slowly improved. The patient reported this  was not like sinus infection or vertigo patient had had before. It was much different. Patient was just starting to feel better, and in two days out patient was scheduled for his second vaccine on Apr. 2. Patient reported these symptoms lasted for about a month.
This is a spontaneous report from a contactable physician via a Pfizer sales representative. A 11-year-old male patient received TRUMENBA (LOT M13066; NDC number 0005-0100-10; Expiry Date 30Sep2016), via an unspecified route of administration on 18Jan2016 at 0.5mL on right shoulder. The patient medical history was not reported. Concomitant medication included MENACTRA on right shoulder, HPV9 on left shoulder, tetanus vaccine, all given on 18Jan2016. On 19Jan2016 the patient experienced fatigue, dizziness, high fever 103.9 F, headache, red shoulder all the way to elbow and severe vomiting-threw up four times. Patient was treated with ZOFRAN given either 19Jan2016 or 20Jan2016 because patient kept throwing up and couldn't keep TYLENOL down. All events recovered on 20Jan2016.
blood clot; rash; This case was reported by a consumer via media and described the occurrence of clot blood in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced clot blood (serious criteria GSK medically significant and life threatening) and rash. On an unknown date, the outcome of the clot blood and rash were unknown.   It was unknown if the reporter considered the clot blood and rash to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's friend. The age at vaccination was not reported. The reporter stated that be careful with shingles vaccine if you choose to get it due to horrible side effects. The reporter's friend developed life threating blood clot and horrible rash with the first shot.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR176000:same reporter
On Day 2 March 30 I felt warmth in my head, ears, lips, shoulders, arms . No fever, just a flushed feeling. It still continues on day 12 . Usually appears in the late afternoon.   I also developed itchy rashes on my left arm , right wrist ,right elbow,both knees. It is now day 12 and these rashes disappear and reappear. At this moment it reappeard on my left elbow joint. I also developed joint pain in my elbows and right knee on day 2  . I continue to have the joint pain on day 12 in my right elbow and knee joints. very painful
After about 10 minutes after received the vaccine, patient experienced tunnel vision, feel like passing out, sweating, cold and chill.  No shortness of breath or angioedema.  Patient was alerted and oriented. We decided to go ahead and gave patient 1 dose of EpiPen + 1 dose of Benadryl and a bottle of water. After received EpiPen dose, patients reported to feel better, we asked patient to sit outside at the waiting area to continue monitoring.  However, after about 10 minutes later, patient reported do not feel well, sweating on his palms and feel cold.   At this point we decided to call 911 after asking the patient.  Patient also called his wife to come and pick him up.  While waiting for paramedic to arrive, I tested his blood sugar and his blood sugar is high (286mg/dl).  Patient reported he is type 1 DM and has not have breakfast this morning.   After paramedics arrived, they assisted him to go outside the store to wait for his wife
Information has been received from a physician assistant concerning an 81 year old female patient with chronic obstructive pulmonary disease and "spine problems" who on 15-MAY-2007 was vaccinated SC with 0.65 ml dose of Zostavax (Lot # 656412/01476F). It was reported that on 20-MAY-2007 the patient experienced shingles like rashes on the foot and small of back after vaccination. At the time of report the patient was not recovered. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested. This is in follow-up to report (s) previously submitted on 6/14/2007. Follow up information was received. The patient had a history of chronic obstructive pulmonary disease, spinal disorder and a history of coronary artery disease, hypertension, cardiac failure congestive, gastrooesophageal reflux disease, spintal stenosis nos, bipolar disorder and sleep apnea. The patient had no known drug allergies. On 20-MAY-2007, the patient was vaccinated at 11:02 in the left arm with a dose of ZOSTAVAX (Oka/Merck) (Lot # 656412/1476F). The patient developed "shingles like rash after vaccination. The patient developed rash at top of gluteal fold and along top of left foot and pain. The patient recovered after 24-MAY-2007 of shingles like rash and pain. Additional information is not expected.
Red, Swollen, itchy, hard, painful, injection site x 2 weeks.   Not resolved after 2 weeks.
10 minutes after shot, (10:20am) my shirt was soaked with sweat and I felt very nauseated. Symptoms are normal so I went back to work (roughly 10:45 am)Noticed that my left leg was numb/had tingles. Slowly my entire left side minus face became heavier, number, had tingling sensations, and noticed shooting pains all on left side. I went to walk these symptoms off thinking this was just in my head. I noticed blurriness in my left eye, felt disoriented, and became extremely nauseated when walking to the bathroom to vomit. I threw up and went directly to my car to call my girlfriend and tell her that I am not feeling well. While on the phone with her, my left side went completely paralyzed, I felt the weirdest feeling that I could not describe, began stuttering "I'm" (I was trying to tell her that I'm dying) without anyway to stop for roughly 2-3 mins while on the phone. Concerned she came right away and took me to Urgent Care (roughly 1pm). They said everything seemed okay neurologically and did a FACT test and said I'm too young to have a stroke and the risk is so low that no MRI is needed. Sent me home and said I had "normal" symptoms to a vaccine. Dr. sent my information to an Allergist who feels because I did not go into anaphylactic  shock that she recommends the second dose. Obviously, not satisfied with the experience there, I have set an appointment with my primary doctor tomorrow 10/20/2021 to discuss this further. By 9pm yesterday, roughly 11 hours after shot, I felt almost completely normal. I'm deathly afraid of the second shot but am a government worker and required by an Executive Order to get the next dose. I am honestly fearful for my life and am going to demand an MRI/blood work tomorrow to determine if I am one of the few who suffered from serious adverse side effects.
Vaccination site pain; Vaccination site swelling; Vaccination site erythema; muscle pain; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included steroid injections. Concurrent medical conditions included sciatica (Chronic pain).   In April 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a year after receiving Shingrix, the patient experienced injection site pain, injection site swelling, injection site erythema and muscle pain. On an unknown date, the outcome of the injection site pain, injection site swelling, injection site erythema and muscle pain were recovered/resolved.   It was unknown if the reporter considered the injection site pain, injection site swelling, injection site erythema and muscle pain to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not provided. The patient received Shingrix approximately 2 months before. The patient states that the symptoms injection site pain, injection site swelling, injection site erythema and severe muscle pain lasted for approximately 1 to 2 weeks. The reporter did not consented to follow-up. The patient did not wish to provide any additional details or contact information.
I received my second dose around 11 AM. 12 hours later, I woke up with chills and a fever (101.8). This lasted for 4 hours. Since my second shot, I have felt extreme fatigue abs muscle soreness. I am a healthy, fit, 37 year old woman. I suspected I had covid in December after direct exposure followed days later by loss of taste, flu-like symptoms and pink eye. My test was negative.
Tingling in face - off and on each day for 4 days  Achiness, chills - 36 hours
sick; Initial information was received 04-Dec-2022 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-health-care professional.  This case involves an unknown age and unknown gender patient who experienced sick while receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (lot number, expiry date: not reported) via unknown route in unknown administration site (form, strength: unknown) for prophylactic vaccination.  On an unknown date the patient developed a non-serious event of sick (illness) (latency: Unknown) following the administration of influenza vaccine.  It was reported, " I got my flu shot and just got over a raging case of influenza A...I was so sick...even with a flu shot."  Action taken with influenza vaccine was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.
Sudden onset confusion and agitation over two hours after vaccination. Patient admitted to the hospital for confusion and additional findings on clinical exam include hyperalgesia, increased tone to upper extremities, and inattention.
No adverse effects reported.; patient was vaccinated with improperly stored dose of Varivax; This spontaneous report was received from a physician refers to a 4 year old patient of unknown gender. No information was provided regarding the patient's medical history, concurrent conditions, allergies or concomitant medications.  On 10-JAN-2019, the patient was vaccinated with improperly stored dose of varicella virus vaccine live (oka/merck) (VARIVAX) for prophylaxis (lot # R002509 with expiration date on 25-JAN-2020, dose, frequency, route of administration were not reported), The vaccine was reconstitute with properly store sterile diluent (dose, frequency, route of administration, lot number and expiration date were not reported).    Administered dose of vaccine experienced temperature excursion between 6 degrees Fahrenheit up to 14 degrees Fahrenheit (14.2 F) for 3 hours and 15 degrees Fahrenheit up to 46 degrees Fahrenheit (30.6 F) for 2 days, 16 hours and 15 minutes. There was a previous temperature excursion for 6 degrees Fahrenheit up to 14 degrees Fahrenheit (11.3 F) for 7 hours and 20 minutes. Digital data logger was involved. No adverse effects were reported.; Sender's Comments:  US-009507513-1905USA003150: US-009507513-1905USA003151: US-009507513-1905USA003152:
History of prior acute shingles two ears ago with post herpetic neuralgia She then had first Zoster vaccine every with Shingrix 11/6. After this she had sore red dot at Shingrix administration site. Then a week or so after, her chronic post herpetic neuralgia pain was much worse like she was having acute shingles again. She states one small fluid filled vesicle appeared in the anterior part of this dermatome. Over several weeks her post herpetic neuralgia pain returned to baseline.
Pain and warmth/swelling at the site. Migraine headache. Required 2 ER visits 7/11/15 & 7/13/15 with medical treatment (phenergan, decadron, morphine, Vicodin, Percocet, NS bolus, Reglan) received prescription for Flexeril and Fioricet.
102.5 F fever; Chills; Headache; Dizziness; Body aches; Fatigue; Nausea; This is a spontaneous report from a contactable Other HCP (patient). This 24-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 19Dec2020 12:00 at single dose on left arm for COVID-19 immunization. Medical history was not reported. Concomitant medications included vortioxetine hydrobromide (TRINTELLIX) and levothyroxine, both received within 2 weeks of vaccination. Facility that the most recent COVID-19 vaccine was administered in Hospital. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. The patient experienced 102.5 F fever, chills, headache, dizziness, body aches, fatigue, nausea on 19Dec2020 23:00. The outcome of 102.5 F fever, chills, headache, dizziness, body aches, fatigue was recovering, of nausea was unknown. No treatment received for the adverse event. The events were assessed non-serious.   Information about lot/batch number has been requested.
Racing heart beat, face felt funny as if harder to move facial muscles. Also lightheaded but not quite dizzy.  It subsided after a few hours on its own. Did not go to a doctor or report it at the time but it was the second time it happened. First was in 2009 with similar symptoms and results. Got the flu shot in the intervening years and had no issues.
Patient reports a large, raised red welt at the injection site as well as red flat welts down her arm for about 5 inches
No adverse effects for the first two weeks.  The morning of 2/7/21 he claimed he was not able to sleep the night before.  He was cold, but only wanted something cold to drink.  He was not able to get through his normal morning routine.  By 8 am we was beginning to get confused and weaker.  By 9 am he vomited and was not able to stand up or walk.  The confusion was increasing.  We called 911.  When they arrived he had chills and was agitated.  He did not have a fever at that time.  He was transported to the emergency room.  We were not able to accompany him there, but were told he was confused, agitated and combatant.  His fever was up to 101 degrees.   The started him on antibiotics and began tests.  He tested negative for COVID and the flu.  By that evening they diagnosed him with viral meningitis and admitted him to the hospital.  The next day we were told that they had ruled out viral meningitis as well as other infections.  The infectious disease doctor said that all tests had come back negative, but they were continuing  to give him antibiotics.  A neurologist and cardiologist were called in and they were not able to find anything either.  He did complain of chest pains, but it was determined that it might be heart burn.  They did see a sign of Afib, but test were not conclusive. On Friday, Feb. 12th he was sent home with antibiotics and heart medicines.  The confusion has improved, but he is very weak and not mobile without assistance.
Diarrhea, intestinal cramps, vomiting,  and a severe reaction to ibuprofen that was not present prior to vaccine
Information regarding PREVNAR 13 was received from a consumer regarding a 3-year-old female patient who experienced irritability, "fever of 103 degrees Fahrenheit" and decreased sleep. The patient received a dose on 28-Jul-2010. The patient experienced irritability, "fever of 103 degrees Fahrenheit" and decreased sleep on 03-Aug-2010. Outcome for irritability and decreased sleep was not recovered. Outcome for fever was recovering. No additional information was available at the time of this report.
this is 1 of 4 pt, out of 35pt pt devel an inj site rxn, characterized by redness & itching, immed p/vax;pt also exp itching in the opposite arm;
Large local reaction to AVA #6 see attached also microscopic hematuria. Service member received AVA#6 on 18Sep in the right triceps region. He received no other vaccines simultaneously, was well at the time and taking no medications. Vaccination was given according to correct FDA schedule. By the evening of 19Sep04 upper rt arm was swollen, hot and red. On 20Sep04 symptoms were worse and erythema extended to the mid forearm on posterior side. Reports he had slight nausea 2 days after immunization that resolved but no other systemic symptoms. States had minor local reactions to other anthrax immunizations. Today member presents with swelling and erythema in extending beyond elbow. Complains of pain in the right elbow and shoulder also. Tingling in the right 3rd-5th fingers experienced last night has subsided.
Complaining of facial itching and feeling swollen. Denies shortness of breath. No wheezing observed. No obvious facial edema or any skin eruptions noted. Given Benadryl 25mg PO stat. Left ambulatory without any signs of distress.
p/vax pt legs & arms felt heavy 48hr p/vax;pt c/o abd cramping & need to sleep all the time;saw MD;told had rxn to flu shot;
Tingling sensation in tongue within 2 minutes of injection, swelling of tongue to twice the thickness, itchy mouth, and rapid heartrate within 10 minutes, redness, burning, swelling, and itchy skin on face within 15 minutes. Epi-pen given within 14 minutes, and transport to hospital, wheezing in bases of lungs noted by ER physician and diphenhydramine, famotidine, and solumedrol given. Swelling of tongue took 1.5 hours to reduce to half. Overnight stay at hospital, due to severity and duration of symptoms.
The patient came to our offsite COVID-19 vaccination clinic. She denied previous vaccination and requested Novavax. Initial Impact search by receptionist showed no previous history of vaccination for COVID-19.  Patient was screened by three individuals who asked if she previously received a COVID-19 vaccination; she denied each time. After the clinic, when her vaccination was being entered into Impactsiis,, it was discovered that the patient had previously received a primary series of Moderna (3/23/21 and 4/20/2021) and a booster of Pfizer (11/30/2021). Patient did not report any side effects post vaccination during the observation period. Several attempts were made to contact the patient (phone call, text, email) in order to clarify her record; unable to reach patient.
pt vax 18JUL 3 hr later devel new onset sz, afeb; devel fever p/admission then had another sz; etiology unk; idiopathic vs febrile sz vs vax rxn vs ?congenital cause;
Patient received the high dose flu vaccine on September 13 2018. A few hours after the shot, the patient started having flu like symptoms including fever, sweats, and shakes. This continued into the evening until ambulance was contacted and she was brought to hospital. Patient was admitted to hospital around 1130pm that evening and stayed until her discharge midday on Sep 15th. She was placed under observation due to her flu like symptoms. Patient does have a history of COPD.
swelling/bruising of injection site; swelling/bruising of injection site; bleeding of injection site; fever; headache; muscle pain; joint aches; red itchy bumps on legs; tiredness; nausea; feeling unwell; itchy skin; This is a spontaneous report from a contactable consumer or other non hcp. A 21-years-old female (Non pregnant) patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration, administered in Left Arm on 13Aug2021 16:30 for covid-19 immunization. The patient medication history were not reported. The patient concomitant medications were not reported. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient received birth control medication within 2 weeks of vaccination. Prior to vaccination the patient did not diagnosed with COVID-19. Since the vaccination the patient did not tested for COVID-19. On 14Aug2021, patient experienced swelling/bruising of injection site, bleeding of injection site, fever, headache, muscle pain, joint aches, red itchy bumps on legs, tiredness, nausea, feeling unwell, itchy skin. Outcome of event was not recovered.